MLCK inhibitor; Presenting Author: MANASKUMAR PANIGRAHI Additional Authors: SHIVARAMPRASAD SINGH, BIJAY MISRA, AYASKANTA SINGH, SANJIBKUMAR KAR, DEBASIS MISRA, GIRISHKUMAR PATI Corresponding Author: MANASKUMAR PANIGRAHI Affiliations: S.C.B Medical college Objective: Nonalcoholic fatty liver disease (NAFLD) is considered the INCB024360 ic50 hepatic manifestation of insulin resistance [IR]. However, a significant proportion ofNAFLD patients are devoid of IR. Is NAFLD sans IR a different entity? The aim was to compare the anthropometric,

metabolic, biochemical, ultrasonography, and histological profile of NAFLD patients with and without IR Methods: Retrospective analyses of 336 NAFLD patients diagnosed during the last two year was done. Patients without IR were compared with those with IR. Results: Out selleck chemical of 336 patients, 153 [45.53%] were without IR. Although age, gender, BMI and transaminase levels were comparable, significantly higher proportion patients in non-IR group had transaminitis; [67.97% vs. 56.83%; p = 0.036] and mild fatty change on ultrasonography; [78.43% vs. 67.21%; P = 0.022]. Diabetes was significantly less common in patients without IR [11.11% vs. 26.23%; P =0.002]. Serum Triglyceride (Tg) [178.5278.78 vs. 204.8694.72;

P = 0.02], FBG [85.3913.80 vs. 98.9331.56; P = 0.00], PGBG [123.7636.77 vs. 148.0764.67; P = 0.00], serum insulin [6.332.18 vs. 15.3912.56; P =0.00] was significantly lower in patients without IR. Liver biopsy was performed in 17/30 patients in non-IR group. Comparison of histology showed no significant difference

between mean NAFLD Activity Score ,presence of borderline nonalcoholic steatohepatitis (NASH), definite NASH or fibrosis stage . Conclusion: Nearly half of our NAFLD population was without IR. Despite MCE mild fatty change on ultrasonography, about a third of them had significant fibrosis. NAFLD is probably a heterogeneous disease and IR is not the sole factor responsible for NAFLD; further studies are needed to find out other possible etiological factors. Key Word(s): 1. NAFLD; 2. NASH; 3. Insulin resistance; 4. Fibrosis; Presenting Author: FOROUGH ASKARIMOGHADAM Additional Authors: AKBAR ARJMANDPOUR, PEIMAN ADIBI Corresponding Author: AKBAR ARJMANDPOUR, FOROUGH ASKARIMOGHADAM Affiliations: Shariati hospital; shariati hospital; shariati Hospital Objective: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder in the world. Insulin resistance and oxidative stress are known factors in pathogenesis of the disease.Metformin is an oral hypoglycemic agent known to improve insulin resistance and vitamin E is an antioxidant agent .Therefore, we aimed to compare the effect of metformin plus vitamin E versus metformin alone on the biochemical and sonographic parameters of NAFLD in a group of patients. Methods: This is an open-label, single center, randomized clinical trial study.